Need help finding what you are looking for?
Contact Us
PUBLISHER: Global Insight Services | PRODUCT CODE: 1650405
PUBLISHER: Global Insight Services | PRODUCT CODE: 1650405
RNA-Based Therapeutics and Vaccines Market Analysis and Forecast to 2033: Type, Product, Technology, Application, End User, Component, Stage, Services, Mode
PUBLISHED:
PAGES: 338 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
RNA-Based Therapeutics and Vaccines Market is anticipated to expand from $4.8 billion in 2023 to $25.3 billion by 2033, growing at a CAGR of approximately 18.1%. The RNA-Based Therapeutics and Vaccines Market encompasses the development and commercialization of treatments and immunizations utilizing ribonucleic acid technologies. This sector includes mRNA vaccines, RNA interference therapies, and antisense oligonucleotides, targeting a range of diseases from infectious ailments to genetic disorders. The market is driven by advancements in biotechnology, increased investment in research, and a growing demand for personalized medicine, offering innovative solutions with the potential for high efficacy and rapid development timelines.
Market Overview
The RNA-Based Therapeutics and Vaccines Market is witnessing robust growth, particularly in the mRNA therapeutics sub-segment, driven by advancements in technology and successful COVID-19 vaccine deployment. This sub-segment is the top performer, owing to its potential in treating various diseases beyond infectious ones, including cancer and genetic disorders. Antisense RNA therapeutics emerge as the second-highest performing sub-segment, propelled by their role in gene expression modulation and increasing investments in genetic research. Regionally, North America leads the market due to strong research infrastructure, government support, and high adoption rates of novel therapies. Europe follows closely, benefiting from strategic collaborations and a favorable regulatory environment. Within these regions, the United States and Germany are key contributors, reflecting their commitment to innovation and healthcare advancements. Asia-Pacific is poised for significant growth, driven by increasing healthcare expenditure, expanding biotechnology sectors, and rising prevalence of chronic diseases, making it a lucrative opportunity for stakeholders.
| Market Segmentation | |
|---|---|
| Type | mRNA-Based Therapeutics, siRNA-Based Therapeutics, miRNA-Based Therapeutics, shRNA-Based Therapeutics, RNA Interference, RNA Aptamers, RNA Vaccines, Antisense RNA |
| Product | RNA-Based Drugs, RNA-Based Vaccines, RNA-Based Diagnostics |
| Technology | Lipid Nanoparticles, RNA Delivery Platforms, CRISPR Technology, RNA Sequencing, RNA Synthesis |
| Application | Oncology, Infectious Diseases, Cardiovascular Diseases, Genetic Disorders, Metabolic Disorders, Neurological Disorders, Rare Diseases |
| End User | Pharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations |
| Component | RNA Molecules, Delivery Systems, Formulation Components |
| Stage | Discovery, Preclinical, Clinical Trials, Commercialization |
| Services | Custom Synthesis, Analytical Services, Consulting Services, Regulatory Services |
| Mode | In Vivo, In Vitro, Ex Vivo |
Key Companies
Bio NTech, Moderna, Cure Vac, Arcturus Therapeutics, Translate Bio, Sangamo Therapeutics, Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Arrowhead Pharmaceuticals, Silence Therapeutics, Pro QR Therapeutics, Arbutus Biopharma, Marina Biotech, Benitec Biopharma, Regulus Therapeutics, Intellia Therapeutics, Beam Therapeutics, Editas Medicine
Sources
World Health Organization, National Institutes of Health, European Medicines Agency, U.S. Food and Drug Administration, Centers for Disease Control and Prevention, World Bank - Health Nutrition and Population Statistics, Global RNA Summit, International Society for RNA Research, American Society of Gene & Cell Therapy, International Society for Vaccines, European Society of Clinical Microbiology and Infectious Diseases, International Vaccine Institute, Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Wellcome Trust, Harvard University - Department of Immunology and Infectious Diseases, Massachusetts Institute of Technology - RNA Therapeutics Program, University of Oxford - Jenner Institute, Stanford University School of Medicine, Johns Hopkins Bloomberg School of Public Health
Research Scope
- Estimates and forecasts the overall market size across type, application, and region.
- Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
- Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
- Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
- Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
- Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
- Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.
Product Code: GIS31566
TABLE OF CONTENTS
1: RNA-Based Therapeutics and Vaccines Market Overview
- 1.1 Objectives of the Study
- 1.2 RNA-Based Therapeutics and Vaccines Market Definition and Scope of the Report
- 1.3 Report Limitations
- 1.4 Years & Currency Considered in the Study
- 1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation
2: Executive Summary
- 2.1 Summary
- 2.2 Key Opinion Leaders
- 2.3 Key Highlights of the Market, by Type
- 2.4 Key Highlights of the Market, by Product
- 2.5 Key Highlights of the Market, by Technology
- 2.6 Key Highlights of the Market, by Application
- 2.7 Key Highlights of the Market, by End User
- 2.8 Key Highlights of the Market, by Component
- 2.9 Key Highlights of the Market, by Stage
- 2.10 Key Highlights of the Market, by Services
- 2.11 Key Highlights of the Market, by Mode
- 2.12 Key Highlights of the Market, by North America
- 2.13 Key Highlights of the Market, by Europe
- 2.14 Key Highlights of the Market, by Asia-Pacific
- 2.15 Key Highlights of the Market, by Latin America
- 2.16 Key Highlights of the Market, by Middle East
- 2.17 Key Highlights of the Market, by Africa
3: Premium Insights on the Market
- 3.1 Market Attractiveness Analysis, by Region
- 3.2 Market Attractiveness Analysis, by Type
- 3.3 Market Attractiveness Analysis, by Product
- 3.4 Market Attractiveness Analysis, by Technology
- 3.5 Market Attractiveness Analysis, by Application
- 3.6 Market Attractiveness Analysis, by End User
- 3.7 Market Attractiveness Analysis, by Component
- 3.8 Market Attractiveness Analysis, by Stage
- 3.9 Market Attractiveness Analysis, by Services
- 3.10 Market Attractiveness Analysis, by Mode
- 3.11 Market Attractiveness Analysis, by North America
- 3.12 Market Attractiveness Analysis, by Europe
- 3.13 Market Attractiveness Analysis, by Asia-Pacific
- 3.14 Market Attractiveness Analysis, by Latin America
- 3.15 Market Attractiveness Analysis, by Middle East
- 3.16 Market Attractiveness Analysis, by Africa
4: RNA-Based Therapeutics and Vaccines Market Outlook
- 4.1 RNA-Based Therapeutics and Vaccines Market Segmentation
- 4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.2 Market Trends
- 4.2.3 Market Restraints
- 4.2.4 Market Opportunities
- 4.3 Porters Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Supplier
- 4.3.5 Competitive Rivalry
- 4.4 PESTLE Analysis
- 4.5 Value Chain Analysis
- 4.6 4Ps Model
- 4.7 ANSOFF Matrix
5: RNA-Based Therapeutics and Vaccines Market Strategy
- 5.1 Parent Market Analysis
- 5.2 Supply-Demand Analysis
- 5.3 Consumer Buying Interest
- 5.4 Case Study Analysis
- 5.5 Pricing Analysis
- 5.6 Regulatory Landscape
- 5.7 Supply Chain Analysis
- 5.8 Competition Product Analysis
- 5.9 Recent Developments
6: RNA-Based Therapeutics and Vaccines Market Size
- 6.1 RNA-Based Therapeutics and Vaccines Market Size, by Value
- 6.2 RNA-Based Therapeutics and Vaccines Market Size, by Volume
7: RNA-Based Therapeutics and Vaccines Market, by Type
- 7.1 Market Overview
- 7.2 mRNA-Based Therapeutics
- 7.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2 Market Size and Forecast, by Region
- 7.3 siRNA-Based Therapeutics
- 7.3.1 Key Market Trends & Opportunity Analysis
- 7.3.2 Market Size and Forecast, by Region
- 7.4 miRNA-Based Therapeutics
- 7.4.1 Key Market Trends & Opportunity Analysis
- 7.4.2 Market Size and Forecast, by Region
- 7.5 shRNA-Based Therapeutics
- 7.5.1 Key Market Trends & Opportunity Analysis
- 7.5.2 Market Size and Forecast, by Region
- 7.6 RNA Interference
- 7.6.1 Key Market Trends & Opportunity Analysis
- 7.6.2 Market Size and Forecast, by Region
- 7.7 RNA Aptamers
- 7.7.1 Key Market Trends & Opportunity Analysis
- 7.7.2 Market Size and Forecast, by Region
- 7.8 RNA Vaccines
- 7.8.1 Key Market Trends & Opportunity Analysis
- 7.8.2 Market Size and Forecast, by Region
- 7.9 Antisense RNA
- 7.9.1 Key Market Trends & Opportunity Analysis
- 7.9.2 Market Size and Forecast, by Region
- 7.10 Others
- 7.10.1 Key Market Trends & Opportunity Analysis
- 7.10.2 Market Size and Forecast, by Region
8: RNA-Based Therapeutics and Vaccines Market, by Product
- 8.1 Market Overview
- 8.2 RNA-Based Drugs
- 8.2.1 Key Market Trends & Opportunity Analysis
- 8.2.2 Market Size and Forecast, by Region
- 8.3 RNA-Based Vaccines
- 8.3.1 Key Market Trends & Opportunity Analysis
- 8.3.2 Market Size and Forecast, by Region
- 8.4 RNA-Based Diagnostics
- 8.4.1 Key Market Trends & Opportunity Analysis
- 8.4.2 Market Size and Forecast, by Region
- 8.5 Others
- 8.5.1 Key Market Trends & Opportunity Analysis
- 8.5.2 Market Size and Forecast, by Region
9: RNA-Based Therapeutics and Vaccines Market, by Technology
- 9.1 Market Overview
- 9.2 Lipid Nanoparticles
- 9.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2 Market Size and Forecast, by Region
- 9.3 RNA Delivery Platforms
- 9.3.1 Key Market Trends & Opportunity Analysis
- 9.3.2 Market Size and Forecast, by Region
- 9.4 CRISPR Technology
- 9.4.1 Key Market Trends & Opportunity Analysis
- 9.4.2 Market Size and Forecast, by Region
- 9.5 RNA Sequencing
- 9.5.1 Key Market Trends & Opportunity Analysis
- 9.5.2 Market Size and Forecast, by Region
- 9.6 RNA Synthesis
- 9.6.1 Key Market Trends & Opportunity Analysis
- 9.6.2 Market Size and Forecast, by Region
- 9.7 Others
- 9.7.1 Key Market Trends & Opportunity Analysis
- 9.7.2 Market Size and Forecast, by Region
10: RNA-Based Therapeutics and Vaccines Market, by Application
- 10.1 Market Overview
- 10.2 Oncology
- 10.2.1 Key Market Trends & Opportunity Analysis
- 10.2.2 Market Size and Forecast, by Region
- 10.3 Infectious Diseases
- 10.3.1 Key Market Trends & Opportunity Analysis
- 10.3.2 Market Size and Forecast, by Region
- 10.4 Cardiovascular Diseases
- 10.4.1 Key Market Trends & Opportunity Analysis
- 10.4.2 Market Size and Forecast, by Region
- 10.5 Genetic Disorders
- 10.5.1 Key Market Trends & Opportunity Analysis
- 10.5.2 Market Size and Forecast, by Region
- 10.6 Metabolic Disorders
- 10.6.1 Key Market Trends & Opportunity Analysis
- 10.6.2 Market Size and Forecast, by Region
- 10.7 Neurological Disorders
- 10.7.1 Key Market Trends & Opportunity Analysis
- 10.7.2 Market Size and Forecast, by Region
- 10.8 Rare Diseases
- 10.8.1 Key Market Trends & Opportunity Analysis
- 10.8.2 Market Size and Forecast, by Region
- 10.9 Others
- 10.9.1 Key Market Trends & Opportunity Analysis
- 10.9.2 Market Size and Forecast, by Region
11: RNA-Based Therapeutics and Vaccines Market, by End User
- 11.1 Market Overview
- 11.2 Pharmaceutical Companies
- 11.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2 Market Size and Forecast, by Region
- 11.3 Biotechnology Companies
- 11.3.1 Key Market Trends & Opportunity Analysis
- 11.3.2 Market Size and Forecast, by Region
- 11.4 Academic Research Institutes
- 11.4.1 Key Market Trends & Opportunity Analysis
- 11.4.2 Market Size and Forecast, by Region
- 11.5 Contract Research Organizations
- 11.5.1 Key Market Trends & Opportunity Analysis
- 11.5.2 Market Size and Forecast, by Region
- 11.6 Others
- 11.6.1 Key Market Trends & Opportunity Analysis
- 11.6.2 Market Size and Forecast, by Region
12: RNA-Based Therapeutics and Vaccines Market, by Component
- 12.1 Market Overview
- 12.2 RNA Molecules
- 12.2.1 Key Market Trends & Opportunity Analysis
- 12.2.2 Market Size and Forecast, by Region
- 12.3 Delivery Systems
- 12.3.1 Key Market Trends & Opportunity Analysis
- 12.3.2 Market Size and Forecast, by Region
- 12.4 Formulation Components
- 12.4.1 Key Market Trends & Opportunity Analysis
- 12.4.2 Market Size and Forecast, by Region
- 12.5 Others
- 12.5.1 Key Market Trends & Opportunity Analysis
- 12.5.2 Market Size and Forecast, by Region
13: RNA-Based Therapeutics and Vaccines Market, by Stage
- 13.1 Market Overview
- 13.2 Discovery
- 13.2.1 Key Market Trends & Opportunity Analysis
- 13.2.2 Market Size and Forecast, by Region
- 13.3 Preclinical
- 13.3.1 Key Market Trends & Opportunity Analysis
- 13.3.2 Market Size and Forecast, by Region
- 13.4 Clinical Trials
- 13.4.1 Key Market Trends & Opportunity Analysis
- 13.4.2 Market Size and Forecast, by Region
- 13.5 Commercialization
- 13.5.1 Key Market Trends & Opportunity Analysis
- 13.5.2 Market Size and Forecast, by Region
- 13.6 Others
- 13.6.1 Key Market Trends & Opportunity Analysis
- 13.6.2 Market Size and Forecast, by Region
14: RNA-Based Therapeutics and Vaccines Market, by Services
- 14.1 Market Overview
- 14.2 Custom Synthesis
- 14.2.1 Key Market Trends & Opportunity Analysis
- 14.2.2 Market Size and Forecast, by Region
- 14.3 Analytical Services
- 14.3.1 Key Market Trends & Opportunity Analysis
- 14.3.2 Market Size and Forecast, by Region
- 14.4 Consulting Services
- 14.4.1 Key Market Trends & Opportunity Analysis
- 14.4.2 Market Size and Forecast, by Region
- 14.5 Regulatory Services
- 14.5.1 Key Market Trends & Opportunity Analysis
- 14.5.2 Market Size and Forecast, by Region
- 14.6 Others
- 14.6.1 Key Market Trends & Opportunity Analysis
- 14.6.2 Market Size and Forecast, by Region
15: RNA-Based Therapeutics and Vaccines Market, by Mode
- 15.1 Market Overview
- 15.2 In Vivo
- 15.2.1 Key Market Trends & Opportunity Analysis
- 15.2.2 Market Size and Forecast, by Region
- 15.3 In Vitro
- 15.3.1 Key Market Trends & Opportunity Analysis
- 15.3.2 Market Size and Forecast, by Region
- 15.4 Ex Vivo
- 15.4.1 Key Market Trends & Opportunity Analysis
- 15.4.2 Market Size and Forecast, by Region
- 15.5 Others
- 15.5.1 Key Market Trends & Opportunity Analysis
- 15.5.2 Market Size and Forecast, by Region
1: RNA-Based Therapeutics and Vaccines Market, by Region
- 16.1 Overview
- 16.2 North America
- 16.2.1 Key Market Trends and Opportunities
- 16.2.2 North America Market Size and Forecast, by Type
- 16.2.3 North America Market Size and Forecast, by Product
- 16.2.4 North America Market Size and Forecast, by Technology
- 16.2.5 North America Market Size and Forecast, by Application
- 16.2.6 North America Market Size and Forecast, by End User
- 16.2.7 North America Market Size and Forecast, by Component
- 16.2.8 North America Market Size and Forecast, by Stage
- 16.2.9 North America Market Size and Forecast, by Services
- 16.2.10 North America Market Size and Forecast, by Mode
- 16.2.11 North America Market Size and Forecast, by Country
- 16.2.12 United States
- 16.2.9.1 United States Market Size and Forecast, by Type
- 16.2.9.2 United States Market Size and Forecast, by Product
- 16.2.9.3 United States Market Size and Forecast, by Technology
- 16.2.9.4 United States Market Size and Forecast, by Application
- 16.2.9.5 United States Market Size and Forecast, by End User
- 16.2.9.6 United States Market Size and Forecast, by Component
- 16.2.9.7 United States Market Size and Forecast, by Stage
- 16.2.9.8 United States Market Size and Forecast, by Services
- 16.2.9.9 United States Market Size and Forecast, by Mode
- 16.2.9.10 Local Competition Analysis
- 16.2.9.11 Local Market Analysis
- 16.2.1 Canada
- 16.2.10.1 Canada Market Size and Forecast, by Type
- 16.2.10.2 Canada Market Size and Forecast, by Product
- 16.2.10.3 Canada Market Size and Forecast, by Technology
- 16.2.10.4 Canada Market Size and Forecast, by Application
- 16.2.10.5 Canada Market Size and Forecast, by End User
- 16.2.10.6 Canada Market Size and Forecast, by Component
- 16.2.10.7 Canada Market Size and Forecast, by Stage
- 16.2.10.8 Canada Market Size and Forecast, by Services
- 16.2.10.9 Canada Market Size and Forecast, by Mode
- 16.2.10.10 Local Competition Analysis
- 16.2.10.11 Local Market Analysis
- 16.1 Europe
- 16.3.1 Key Market Trends and Opportunities
- 16.3.2 Europe Market Size and Forecast, by Type
- 16.3.3 Europe Market Size and Forecast, by Product
- 16.3.4 Europe Market Size and Forecast, by Technology
- 16.3.5 Europe Market Size and Forecast, by Application
- 16.3.6 Europe Market Size and Forecast, by End User
- 16.3.7 Europe Market Size and Forecast, by Component
- 16.3.8 Europe Market Size and Forecast, by Stage
- 16.3.9 Europe Market Size and Forecast, by Services
- 16.3.10 Europe Market Size and Forecast, by Mode
- 16.3.11 Europe Market Size and Forecast, by Country
- 16.3.12 United Kingdom
- 16.3.9.1 United Kingdom Market Size and Forecast, by Type
- 16.3.9.2 United Kingdom Market Size and Forecast, by Product
- 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
- 16.3.9.4 United Kingdom Market Size and Forecast, by Application
- 16.3.9.5 United Kingdom Market Size and Forecast, by End User
- 16.3.9.6 United Kingdom Market Size and Forecast, by Component
- 16.3.9.7 United Kingdom Market Size and Forecast, by Stage
- 16.3.9.8 United Kingdom Market Size and Forecast, by Services
- 16.3.9.9 United Kingdom Market Size and Forecast, by Mode
- 16.3.9.10 Local Competition Analysis
- 16.3.9.11 Local Market Analysis
- 16.3.1 Germany
- 16.3.10.1 Germany Market Size and Forecast, by Type
- 16.3.10.2 Germany Market Size and Forecast, by Product
- 16.3.10.3 Germany Market Size and Forecast, by Technology
- 16.3.10.4 Germany Market Size and Forecast, by Application
- 16.3.10.5 Germany Market Size and Forecast, by End User
- 16.3.10.6 Germany Market Size and Forecast, by Component
- 16.3.10.7 Germany Market Size and Forecast, by Stage
- 16.3.10.8 Germany Market Size and Forecast, by Services
- 16.3.10.9 Germany Market Size and Forecast, by Mode
- 16.3.10.10 Local Competition Analysis
- 16.3.10.11 Local Market Analysis
- 16.3.1 France
- 16.3.11.1 France Market Size and Forecast, by Type
- 16.3.11.2 France Market Size and Forecast, by Product
- 16.3.11.3 France Market Size and Forecast, by Technology
- 16.3.11.4 France Market Size and Forecast, by Application
- 16.3.11.5 France Market Size and Forecast, by End User
- 16.3.11.6 France Market Size and Forecast, by Component
- 16.3.11.7 France Market Size and Forecast, by Stage
- 16.3.11.8 France Market Size and Forecast, by Services
- 16.3.11.9 France Market Size and Forecast, by Mode
- 16.3.11.10 Local Competition Analysis
- 16.3.11.11 Local Market Analysis
- 16.3.1 Spain
- 16.3.12.1 Spain Market Size and Forecast, by Type
- 16.3.12.2 Spain Market Size and Forecast, by Product
- 16.3.12.3 Spain Market Size and Forecast, by Technology
- 16.3.12.4 Spain Market Size and Forecast, by Application
- 16.3.12.5 Spain Market Size and Forecast, by End User
- 16.3.12.6 Spain Market Size and Forecast, by Component
- 16.3.12.7 Spain Market Size and Forecast, by Stage
- 16.3.12.8 Spain Market Size and Forecast, by Services
- 16.3.12.9 Spain Market Size and Forecast, by Mode
- 16.3.12.10 Local Competition Analysis
- 16.3.12.11 Local Market Analysis
- 16.3.1 Italy
- 16.3.13.1 Italy Market Size and Forecast, by Type
- 16.3.13.2 Italy Market Size and Forecast, by Product
- 16.3.13.3 Italy Market Size and Forecast, by Technology
- 16.3.13.4 Italy Market Size and Forecast, by Application
- 16.3.13.5 Italy Market Size and Forecast, by End User
- 16.3.13.6 Italy Market Size and Forecast, by Component
- 16.3.13.7 Italy Market Size and Forecast, by Stage
- 16.3.13.8 Italy Market Size and Forecast, by Services
- 16.3.13.9 Italy Market Size and Forecast, by Mode
- 16.3.13.10 Local Competition Analysis
- 16.3.13.11 Local Market Analysis
- 16.3.1 Netherlands
- 16.3.14.1 Netherlands Market Size and Forecast, by Type
- 16.3.14.2 Netherlands Market Size and Forecast, by Product
- 16.3.14.3 Netherlands Market Size and Forecast, by Technology
- 16.3.14.4 Netherlands Market Size and Forecast, by Application
- 16.3.14.5 Netherlands Market Size and Forecast, by End User
- 16.3.14.6 Netherlands Market Size and Forecast, by Component
- 16.3.14.7 Netherlands Market Size and Forecast, by Stage
- 16.3.14.8 Netherlands Market Size and Forecast, by Services
- 16.3.14.9 Netherlands Market Size and Forecast, by Mode
- 16.3.14.10 Local Competition Analysis
- 16.3.14.11 Local Market Analysis
- 16.3.1 Sweden
- 16.3.15.1 Sweden Market Size and Forecast, by Type
- 16.3.15.2 Sweden Market Size and Forecast, by Product
- 16.3.15.3 Sweden Market Size and Forecast, by Technology
- 16.3.15.4 Sweden Market Size and Forecast, by Application
- 16.3.15.5 Sweden Market Size and Forecast, by End User
- 16.3.15.6 Sweden Market Size and Forecast, by Component
- 16.3.15.7 Sweden Market Size and Forecast, by Stage
- 16.3.15.8 Sweden Market Size and Forecast, by Services
- 16.3.15.9 Sweden Market Size and Forecast, by Mode
- 16.3.15.10 Local Competition Analysis
- 16.3.15.11 Local Market Analysis
- 16.3.1 Switzerland
- 16.3.16.1 Switzerland Market Size and Forecast, by Type
- 16.3.16.2 Switzerland Market Size and Forecast, by Product
- 16.3.16.3 Switzerland Market Size and Forecast, by Technology
- 16.3.16.4 Switzerland Market Size and Forecast, by Application
- 16.3.16.5 Switzerland Market Size and Forecast, by End User
- 16.3.16.6 Switzerland Market Size and Forecast, by Component
- 16.3.16.7 Switzerland Market Size and Forecast, by Stage
- 16.3.16.8 Switzerland Market Size and Forecast, by Services
- 16.3.16.9 Switzerland Market Size and Forecast, by Mode
- 16.3.16.10 Local Competition Analysis
- 16.3.16.11 Local Market Analysis
- 16.3.1 Denmark
- 16.3.17.1 Denmark Market Size and Forecast, by Type
- 16.3.17.2 Denmark Market Size and Forecast, by Product
- 16.3.17.3 Denmark Market Size and Forecast, by Technology
- 16.3.17.4 Denmark Market Size and Forecast, by Application
- 16.3.17.5 Denmark Market Size and Forecast, by End User
- 16.3.17.6 Denmark Market Size and Forecast, by Component
- 16.3.17.7 Denmark Market Size and Forecast, by Stage
- 16.3.17.8 Denmark Market Size and Forecast, by Services
- 16.3.17.9 Denmark Market Size and Forecast, by Mode
- 16.3.17.10 Local Competition Analysis
- 16.3.17.11 Local Market Analysis
- 16.3.1 Finland
- 16.3.18.1 Finland Market Size and Forecast, by Type
- 16.3.18.2 Finland Market Size and Forecast, by Product
- 16.3.18.3 Finland Market Size and Forecast, by Technology
- 16.3.18.4 Finland Market Size and Forecast, by Application
- 16.3.18.5 Finland Market Size and Forecast, by End User
- 16.3.18.6 Finland Market Size and Forecast, by Component
- 16.3.18.7 Finland Market Size and Forecast, by Stage
- 16.3.18.8 Finland Market Size and Forecast, by Services
- 16.3.18.9 Finland Market Size and Forecast, by Mode
- 16.3.18.10 Local Competition Analysis
- 16.3.18.11 Local Market Analysis
- 16.3.1 Russia
- 16.3.19.1 Russia Market Size and Forecast, by Type
- 16.3.19.2 Russia Market Size and Forecast, by Product
- 16.3.19.3 Russia Market Size and Forecast, by Technology
- 16.3.19.4 Russia Market Size and Forecast, by Application
- 16.3.19.5 Russia Market Size and Forecast, by End User
- 16.3.19.6 Russia Market Size and Forecast, by Component
- 16.3.19.7 Russia Market Size and Forecast, by Stage
- 16.3.19.8 Russia Market Size and Forecast, by Services
- 16.3.19.9 Russia Market Size and Forecast, by Mode
- 16.3.19.10 Local Competition Analysis
- 16.3.19.11 Local Market Analysis
- 16.3.1 Rest of Europe
- 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
- 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
- 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
- 16.3.20.4 Rest of Europe Market Size and Forecast, by Application
- 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
- 16.3.20.6 Rest of Europe Market Size and Forecast, by Component
- 16.3.20.7 Rest of Europe Market Size and Forecast, by Stage
- 16.3.20.8 Rest of Europe Market Size and Forecast, by Services
- 16.3.20.9 Rest of Europe Market Size and Forecast, by Mode
- 16.3.20.10 Local Competition Analysis
- 16.3.20.11 Local Market Analysis
- 16.1 Asia-Pacific
- 16.4.1 Key Market Trends and Opportunities
- 16.4.2 Asia-Pacific Market Size and Forecast, by Type
- 16.4.3 Asia-Pacific Market Size and Forecast, by Product
- 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
- 16.4.5 Asia-Pacific Market Size and Forecast, by Application
- 16.4.6 Asia-Pacific Market Size and Forecast, by End User
- 16.4.7 Asia-Pacific Market Size and Forecast, by Component
- 16.4.8 Asia-Pacific Market Size and Forecast, by Stage
- 16.4.9 Asia-Pacific Market Size and Forecast, by Services
- 16.4.10 Asia-Pacific Market Size and Forecast, by Mode
- 16.4.11 Asia-Pacific Market Size and Forecast, by Country
- 16.4.12 China
- 16.4.9.1 China Market Size and Forecast, by Type
- 16.4.9.2 China Market Size and Forecast, by Product
- 16.4.9.3 China Market Size and Forecast, by Technology
- 16.4.9.4 China Market Size and Forecast, by Application
- 16.4.9.5 China Market Size and Forecast, by End User
- 16.4.9.6 China Market Size and Forecast, by Component
- 16.4.9.7 China Market Size and Forecast, by Stage
- 16.4.9.8 China Market Size and Forecast, by Services
- 16.4.9.9 China Market Size and Forecast, by Mode
- 16.4.9.10 Local Competition Analysis
- 16.4.9.11 Local Market Analysis
- 16.4.1 India
- 16.4.10.1 India Market Size and Forecast, by Type
- 16.4.10.2 India Market Size and Forecast, by Product
- 16.4.10.3 India Market Size and Forecast, by Technology
- 16.4.10.4 India Market Size and Forecast, by Application
- 16.4.10.5 India Market Size and Forecast, by End User
- 16.4.10.6 India Market Size and Forecast, by Component
- 16.4.10.7 India Market Size and Forecast, by Stage
- 16.4.10.8 India Market Size and Forecast, by Services
- 16.4.10.9 India Market Size and Forecast, by Mode
- 16.4.10.10 Local Competition Analysis
- 16.4.10.11 Local Market Analysis
- 16.4.1 Japan
- 16.4.11.1 Japan Market Size and Forecast, by Type
- 16.4.11.2 Japan Market Size and Forecast, by Product
- 16.4.11.3 Japan Market Size and Forecast, by Technology
- 16.4.11.4 Japan Market Size and Forecast, by Application
- 16.4.11.5 Japan Market Size and Forecast, by End User
- 16.4.11.6 Japan Market Size and Forecast, by Component
- 16.4.11.7 Japan Market Size and Forecast, by Stage
- 16.4.11.8 Japan Market Size and Forecast, by Services
- 16.4.11.9 Japan Market Size and Forecast, by Mode
- 16.4.11.10 Local Competition Analysis
- 16.4.11.11 Local Market Analysis
- 16.4.1 South Korea
- 16.4.12.1 South Korea Market Size and Forecast, by Type
- 16.4.12.2 South Korea Market Size and Forecast, by Product
- 16.4.12.3 South Korea Market Size and Forecast, by Technology
- 16.4.12.4 South Korea Market Size and Forecast, by Application
- 16.4.12.5 South Korea Market Size and Forecast, by End User
- 16.4.12.6 South Korea Market Size and Forecast, by Component
- 16.4.12.7 South Korea Market Size and Forecast, by Stage
- 16.4.12.8 South Korea Market Size and Forecast, by Services
- 16.4.12.9 South Korea Market Size and Forecast, by Mode
- 16.4.12.10 Local Competition Analysis
- 16.4.12.11 Local Market Analysis
- 16.4.1 Australia
- 16.4.13.1 Australia Market Size and Forecast, by Type
- 16.4.13.2 Australia Market Size and Forecast, by Product
- 16.4.13.3 Australia Market Size and Forecast, by Technology
- 16.4.13.4 Australia Market Size and Forecast, by Application
- 16.4.13.5 Australia Market Size and Forecast, by End User
- 16.4.13.6 Australia Market Size and Forecast, by Component
- 16.4.13.7 Australia Market Size and Forecast, by Stage
- 16.4.13.8 Australia Market Size and Forecast, by Services
- 16.4.13.9 Australia Market Size and Forecast, by Mode
- 16.4.13.10 Local Competition Analysis
- 16.4.13.11 Local Market Analysis
- 16.4.1 Singapore
- 16.4.14.1 Singapore Market Size and Forecast, by Type
- 16.4.14.2 Singapore Market Size and Forecast, by Product
- 16.4.14.3 Singapore Market Size and Forecast, by Technology
- 16.4.14.4 Singapore Market Size and Forecast, by Application
- 16.4.14.5 Singapore Market Size and Forecast, by End User
- 16.4.14.6 Singapore Market Size and Forecast, by Component
- 16.4.14.7 Singapore Market Size and Forecast, by Stage
- 16.4.14.8 Singapore Market Size and Forecast, by Services
- 16.4.14.9 Singapore Market Size and Forecast, by Mode
- 16.4.14.10 Local Competition Analysis
- 16.4.14.11 Local Market Analysis
- 16.4.1 Indonesia
- 16.4.15.1 Indonesia Market Size and Forecast, by Type
- 16.4.15.2 Indonesia Market Size and Forecast, by Product
- 16.4.15.3 Indonesia Market Size and Forecast, by Technology
- 16.4.15.4 Indonesia Market Size and Forecast, by Application
- 16.4.15.5 Indonesia Market Size and Forecast, by End User
- 16.4.15.6 Indonesia Market Size and Forecast, by Component
- 16.4.15.7 Indonesia Market Size and Forecast, by Stage
- 16.4.15.8 Indonesia Market Size and Forecast, by Services
- 16.4.15.9 Indonesia Market Size and Forecast, by Mode
- 16.4.15.10 Local Competition Analysis
- 16.4.15.11 Local Market Analysis
- 16.4.1 Taiwan
- 16.4.16.1 Taiwan Market Size and Forecast, by Type
- 16.4.16.2 Taiwan Market Size and Forecast, by Product
- 16.4.16.3 Taiwan Market Size and Forecast, by Technology
- 16.4.16.4 Taiwan Market Size and Forecast, by Application
- 16.4.16.5 Taiwan Market Size and Forecast, by End User
- 16.4.16.6 Taiwan Market Size and Forecast, by Component
- 16.4.16.7 Taiwan Market Size and Forecast, by Stage
- 16.4.16.8 Taiwan Market Size and Forecast, by Services
- 16.4.16.9 Taiwan Market Size and Forecast, by Mode
- 16.4.16.10 Local Competition Analysis
- 16.4.16.11 Local Market Analysis
- 16.4.1 Malaysia
- 16.4.17.1 Malaysia Market Size and Forecast, by Type
- 16.4.17.2 Malaysia Market Size and Forecast, by Product
- 16.4.17.3 Malaysia Market Size and Forecast, by Technology
- 16.4.17.4 Malaysia Market Size and Forecast, by Application
- 16.4.17.5 Malaysia Market Size and Forecast, by End User
- 16.4.17.6 Malaysia Market Size and Forecast, by Component
- 16.4.17.7 Malaysia Market Size and Forecast, by Stage
- 16.4.17.8 Malaysia Market Size and Forecast, by Services
- 16.4.17.9 Malaysia Market Size and Forecast, by Mode
- 16.4.17.10 Local Competition Analysis
- 16.4.17.11 Local Market Analysis
- 16.4.1 Rest of Asia-Pacific
- 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
- 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
- 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
- 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
- 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
- 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Component
- 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
- 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Services
- 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
- 16.4.18.10 Local Competition Analysis
- 16.4.18.11 Local Market Analysis
- 16.1 Latin America
- 16.5.1 Key Market Trends and Opportunities
- 16.5.2 Latin America Market Size and Forecast, by Type
- 16.5.3 Latin America Market Size and Forecast, by Product
- 16.5.4 Latin America Market Size and Forecast, by Technology
- 16.5.5 Latin America Market Size and Forecast, by Application
- 16.5.6 Latin America Market Size and Forecast, by End User
- 16.5.7 Latin America Market Size and Forecast, by Component
- 16.5.8 Latin America Market Size and Forecast, by Stage
- 16.5.9 Latin America Market Size and Forecast, by Services
- 16.5.10 Latin America Market Size and Forecast, by Mode
- 16.5.11 Latin America Market Size and Forecast, by Country
- 16.5.12 Brazil
- 16.5.9.1 Brazil Market Size and Forecast, by Type
- 16.5.9.2 Brazil Market Size and Forecast, by Product
- 16.5.9.3 Brazil Market Size and Forecast, by Technology
- 16.5.9.4 Brazil Market Size and Forecast, by Application
- 16.5.9.5 Brazil Market Size and Forecast, by End User
- 16.5.9.6 Brazil Market Size and Forecast, by Component
- 16.5.9.7 Brazil Market Size and Forecast, by Stage
- 16.5.9.8 Brazil Market Size and Forecast, by Services
- 16.5.9.9 Brazil Market Size and Forecast, by Mode
- 16.5.9.10 Local Competition Analysis
- 16.5.9.11 Local Market Analysis
- 16.5.1 Mexico
- 16.5.10.1 Mexico Market Size and Forecast, by Type
- 16.5.10.2 Mexico Market Size and Forecast, by Product
- 16.5.10.3 Mexico Market Size and Forecast, by Technology
- 16.5.10.4 Mexico Market Size and Forecast, by Application
- 16.5.10.5 Mexico Market Size and Forecast, by End User
- 16.5.10.6 Mexico Market Size and Forecast, by Component
- 16.5.10.7 Mexico Market Size and Forecast, by Stage
- 16.5.10.8 Mexico Market Size and Forecast, by Services
- 16.5.10.9 Mexico Market Size and Forecast, by Mode
- 16.5.10.10 Local Competition Analysis
- 16.5.10.11 Local Market Analysis
- 16.5.1 Argentina
- 16.5.11.1 Argentina Market Size and Forecast, by Type
- 16.5.11.2 Argentina Market Size and Forecast, by Product
- 16.5.11.3 Argentina Market Size and Forecast, by Technology
- 16.5.11.4 Argentina Market Size and Forecast, by Application
- 16.5.11.5 Argentina Market Size and Forecast, by End User
- 16.5.11.6 Argentina Market Size and Forecast, by Component
- 16.5.11.7 Argentina Market Size and Forecast, by Stage
- 16.5.11.8 Argentina Market Size and Forecast, by Services
- 16.5.11.9 Argentina Market Size and Forecast, by Mode
- 16.5.11.10 Local Competition Analysis
- 16.5.11.11 Local Market Analysis
- 16.5.1 Rest of Latin America
- 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
- 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
- 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
- 16.5.12.4 Rest of Latin America Market Size and Forecast, by Application
- 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
- 16.5.12.6 Rest of Latin America Market Size and Forecast, by Component
- 16.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
- 16.5.12.8 Rest of Latin America Market Size and Forecast, by Services
- 16.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
- 16.5.12.10 Local Competition Analysis
- 16.5.12.11 Local Market Analysis
- 16.1 Middle East and Africa
- 16.6.1 Key Market Trends and Opportunities
- 16.6.2 Middle East and Africa Market Size and Forecast, by Type
- 16.6.3 Middle East and Africa Market Size and Forecast, by Product
- 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
- 16.6.5 Middle East and Africa Market Size and Forecast, by Application
- 16.6.6 Middle East and Africa Market Size and Forecast, by End User
- 16.6.7 Middle East and Africa Market Size and Forecast, by Component
- 16.6.8 Middle East and Africa Market Size and Forecast, by Stage
- 16.6.9 Middle East and Africa Market Size and Forecast, by Services
- 16.6.10 Middle East and Africa Market Size and Forecast, by Mode
- 16.6.11 Middle East and Africa Market Size and Forecast, by Country
- 16.6.12 Saudi Arabia
- 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
- 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
- 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
- 16.6.9.4 Saudi Arabia Market Size and Forecast, by Application
- 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
- 16.6.9.6 Saudi Arabia Market Size and Forecast, by Component
- 16.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
- 16.6.9.8 Saudi Arabia Market Size and Forecast, by Services
- 16.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
- 16.6.9.10 Local Competition Analysis
- 16.6.9.11 Local Market Analysis
- 16.6.1 UAE
- 16.6.10.1 UAE Market Size and Forecast, by Type
- 16.6.10.2 UAE Market Size and Forecast, by Product
- 16.6.10.3 UAE Market Size and Forecast, by Technology
- 16.6.10.4 UAE Market Size and Forecast, by Application
- 16.6.10.5 UAE Market Size and Forecast, by End User
- 16.6.10.6 UAE Market Size and Forecast, by Component
- 16.6.10.7 UAE Market Size and Forecast, by Stage
- 16.6.10.8 UAE Market Size and Forecast, by Services
- 16.6.10.9 UAE Market Size and Forecast, by Mode
- 16.6.10.10 Local Competition Analysis
- 16.6.10.11 Local Market Analysis
- 16.6.1 South Africa
- 16.6.11.1 South Africa Market Size and Forecast, by Type
- 16.6.11.2 South Africa Market Size and Forecast, by Product
- 16.6.11.3 South Africa Market Size and Forecast, by Technology
- 16.6.11.4 South Africa Market Size and Forecast, by Application
- 16.6.11.5 South Africa Market Size and Forecast, by End User
- 16.6.11.6 South Africa Market Size and Forecast, by Component
- 16.6.11.7 South Africa Market Size and Forecast, by Stage
- 16.6.11.8 South Africa Market Size and Forecast, by Services
- 16.6.11.9 South Africa Market Size and Forecast, by Mode
- 16.6.11.10 Local Competition Analysis
- 16.6.11.11 Local Market Analysis
- 16.6.1 Rest of MEA
- 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
- 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
- 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
- 16.6.12.4 Rest of MEA Market Size and Forecast, by Application
- 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
- 16.6.12.6 Rest of MEA Market Size and Forecast, by Component
- 16.6.12.7 Rest of MEA Market Size and Forecast, by Stage
- 16.6.12.8 Rest of MEA Market Size and Forecast, by Services
- 16.6.12.9 Rest of MEA Market Size and Forecast, by Mode
- 16.6.12.10 Local Competition Analysis
- 16.6.12.11 Local Market Analysis
1: Competitive Landscape
- 17.1 Overview
- 17.2 Market Share Analysis
- 17.3 Key Player Positioning
- 17.4 Competitive Leadership Mapping
- 17.4.1 Star Players
- 17.4.2 Innovators
- 17.4.3 Emerging Players
- 17.5 Vendor Benchmarking
- 17.6 Developmental Strategy Benchmarking
- 17.6.1 New Product Developments
- 17.6.2 Product Launches
- 17.6.3 Business Expansions
- 17.6.4 Partnerships, Joint Ventures, and Collaborations
- 17.6.5 Mergers and Acquisitions
2: Company Profiles
- 18.1 BioNTech
- 18.1.1 Company Overview
- 18.1.2 Company Snapshot
- 18.1.3 Business Segments
- 18.1.4 Business Performance
- 18.1.5 Product Offerings
- 18.1.6 Key Developmental Strategies
- 18.1.7 SWOT Analysis
- 18.2 Moderna
- 18.2.1 Company Overview
- 18.2.2 Company Snapshot
- 18.2.3 Business Segments
- 18.2.4 Business Performance
- 18.2.5 Product Offerings
- 18.2.6 Key Developmental Strategies
- 18.2.7 SWOT Analysis
- 18.3 CureVac
- 18.3.1 Company Overview
- 18.3.2 Company Snapshot
- 18.3.3 Business Segments
- 18.3.4 Business Performance
- 18.3.5 Product Offerings
- 18.3.6 Key Developmental Strategies
- 18.3.7 SWOT Analysis
- 18.4 Arcturus Therapeutics
- 18.4.1 Company Overview
- 18.4.2 Company Snapshot
- 18.4.3 Business Segments
- 18.4.4 Business Performance
- 18.4.5 Product Offerings
- 18.4.6 Key Developmental Strategies
- 18.4.7 SWOT Analysis
- 18.5 Translate Bio
- 18.5.1 Company Overview
- 18.5.2 Company Snapshot
- 18.5.3 Business Segments
- 18.5.4 Business Performance
- 18.5.5 Product Offerings
- 18.5.6 Key Developmental Strategies
- 18.5.7 SWOT Analysis
- 18.6 Sangamo Therapeutics
- 18.6.1 Company Overview
- 18.6.2 Company Snapshot
- 18.6.3 Business Segments
- 18.6.4 Business Performance
- 18.6.5 Product Offerings
- 18.6.6 Key Developmental Strategies
- 18.6.7 SWOT Analysis
- 18.7 Sarepta Therapeutics
- 18.7.1 Company Overview
- 18.7.2 Company Snapshot
- 18.7.3 Business Segments
- 18.7.4 Business Performance
- 18.7.5 Product Offerings
- 18.7.6 Key Developmental Strategies
- 18.7.7 SWOT Analysis
- 18.8 Ionis Pharmaceuticals
- 18.8.1 Company Overview
- 18.8.2 Company Snapshot
- 18.8.3 Business Segments
- 18.8.4 Business Performance
- 18.8.5 Product Offerings
- 18.8.6 Key Developmental Strategies
- 18.8.7 SWOT Analysis
- 18.9 Alnylam Pharmaceuticals
- 18.9.1 Company Overview
- 18.9.2 Company Snapshot
- 18.9.3 Business Segments
- 18.9.4 Business Performance
- 18.9.5 Product Offerings
- 18.9.6 Key Developmental Strategies
- 18.9.7 SWOT Analysis
- 18.10 Dicerna Pharmaceuticals
- 18.10.1 Company Overview
- 18.10.2 Company Snapshot
- 18.10.3 Business Segments
- 18.10.4 Business Performance
- 18.10.5 Product Offerings
- 18.10.6 Key Developmental Strategies
- 18.10.7 SWOT Analysis
- 18.11 Arrowhead Pharmaceuticals
- 18.11.1 Company Overview
- 18.11.2 Company Snapshot
- 18.11.3 Business Segments
- 18.11.4 Business Performance
- 18.11.5 Product Offerings
- 18.11.6 Key Developmental Strategies
- 18.11.7 SWOT Analysis
- 18.12 Silence Therapeutics
- 18.12.1 Company Overview
- 18.12.2 Company Snapshot
- 18.12.3 Business Segments
- 18.12.4 Business Performance
- 18.12.5 Product Offerings
- 18.12.6 Key Developmental Strategies
- 18.12.7 SWOT Analysis
- 18.13 ProQR Therapeutics
- 18.13.1 Company Overview
- 18.13.2 Company Snapshot
- 18.13.3 Business Segments
- 18.13.4 Business Performance
- 18.13.5 Product Offerings
- 18.13.6 Key Developmental Strategies
- 18.13.7 SWOT Analysis
- 18.14 Arbutus Biopharma
- 18.14.1 Company Overview
- 18.14.2 Company Snapshot
- 18.14.3 Business Segments
- 18.14.4 Business Performance
- 18.14.5 Product Offerings
- 18.14.6 Key Developmental Strategies
- 18.14.7 SWOT Analysis
- 18.15 Marina Biotech
- 18.15.1 Company Overview
- 18.15.2 Company Snapshot
- 18.15.3 Business Segments
- 18.15.4 Business Performance
- 18.15.5 Product Offerings
- 18.15.6 Key Developmental Strategies
- 18.15.7 SWOT Analysis
- 18.16 Benitec Biopharma
- 18.16.1 Company Overview
- 18.16.2 Company Snapshot
- 18.16.3 Business Segments
- 18.16.4 Business Performance
- 18.16.5 Product Offerings
- 18.16.6 Key Developmental Strategies
- 18.16.7 SWOT Analysis
- 18.17 Regulus Therapeutics
- 18.17.1 Company Overview
- 18.17.2 Company Snapshot
- 18.17.3 Business Segments
- 18.17.4 Business Performance
- 18.17.5 Product Offerings
- 18.17.6 Key Developmental Strategies
- 18.17.7 SWOT Analysis
- 18.18 Intellia Therapeutics
- 18.18.1 Company Overview
- 18.18.2 Company Snapshot
- 18.18.3 Business Segments
- 18.18.4 Business Performance
- 18.18.5 Product Offerings
- 18.18.6 Key Developmental Strategies
- 18.18.7 SWOT Analysis
- 18.19 Beam Therapeutics
- 18.19.1 Company Overview
- 18.19.2 Company Snapshot
- 18.19.3 Business Segments
- 18.19.4 Business Performance
- 18.19.5 Product Offerings
- 18.19.6 Key Developmental Strategies
- 18.19.7 SWOT Analysis
- 18.20 Editas Medicine
- 18.20.1 Company Overview
- 18.20.2 Company Snapshot
- 18.20.3 Business Segments
- 18.20.4 Business Performance
- 18.20.5 Product Offerings
- 18.20.6 Key Developmental Strategies
- 18.20.7 SWOT Analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.